Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-04-25

Clinical Trial Update: Add on Lacosamide Versus High Dose Monotherapy [Phase 3]

View source ↗

Summary

Phase 3 trial comparing add-on lacosamide to high-dose monotherapy in epilepsy has completed. Results were posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • lacosamide (Vimpat) (lacosamide)

Snippet

Sponsor: Brigham and Women's Hospital | Conditions: Epilepsy | Phase 3 | Status: COMPLETED | Results posted: 2017-04-25